MARKET

DYAI

DYAI

Dyadic Intl Inc Del
NASDAQ
0.7251
+0.0041
+0.57%
Opening 12:36 05/20 EDT
OPEN
0.7469
PREV CLOSE
0.7210
HIGH
0.7498
LOW
0.7251
VOLUME
7.51K
TURNOVER
--
52 WEEK HIGH
1.346
52 WEEK LOW
0.6546
MARKET CAP
26.42M
P/E (TTM)
-3.2127
1D
5D
1M
3M
1Y
5Y
1D
Dyadic International’s Earnings Call Shows Early Momentum
TipRanks · 15h ago
Dyadic COO Hazelton presents at Sidoti Virtual Investor Conference
PUBT · 1d ago
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
Barchart · 1d ago
Weekly Report: what happened at DYAI last week (0511-0515)?
Weekly Report · 2d ago
Dyadic International Earnings Call Highlights Early Momentum
TipRanks · 5d ago
Dyadic outlines cash runway into Q2 2027 while targeting mid-2026 alpha-lactalbumin sampling
Seeking Alpha · 6d ago
Transcript: Dyadic International Q1 2026 Earnings Conference Call
Benzinga · 6d ago
BRIEF-Dyadic Announces First Quarter 2026 Financial Results And Highlights Recent Company Progress
Reuters · 6d ago
More
About DYAI
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Webull offers Dyadic International Inc stock information, including NASDAQ: DYAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DYAI stock methods without spending real money on the virtual paper trading platform.